CTD Holdings to Present at UK Annual Conference for NPC Patients, Families and Caregivers Sep 22, 2017, 8:00 AM EDT
(World News Science)

Conference Brings Together European and International Families and Niemann-Pick Disease Type C Patient Advocates and Health Professionals ALACHUA, FL -- (Marketwired) -- 09/22/17 -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that the company will present on its clinical and drug development program for the orphan drug, Trappsol® CycloTM, at the Niemann-Pick UK 8 Interactive Workshop on Niemann-Pick Diseases and NPUK 24 Annual Family Conference. The conference will take place at the Mecure Haydock Hotel, Haydock, UK, from September 22 to 24. CTD`s...